Molecular remission after RA and chemotherapy.

Molecular remission rates are shown for patients with newly diagnosed APL after treatment with all-trans RA at the time of documented clinical complete remission and after 30 days of maintenance with RA followed by postremission therapy with 1, 2, or 3 cycles of idarubicin and cytarabine.